ARTICLE | Targets & Mechanisms
BetaLogics' in vitro beta cells
October 9, 2014 7:00 AM UTC
BetaLogics Venture and The University of British Columbia have developed an in vitro protocol to generate mature insulin-producing pancreatic b-like cells from human pluripotent stem cells.1 The findings mark a major milestone for the development of new cell-based therapies for diabetes.
Harvard University researchers have separately described an in vitro protocol for generating similar cells but were unable to provide commentary in time for publication.2...